MDSpire - Takeaway
From the Journals

GLP-1 Drugs Examined in Psychiatric Outcomes

Researchers evaluate mental health trajectories with antidiabetic therapies in patients with depression or anxiety.

Share

  • 1

    Semaglutide lowers the risk of worsening mental illness by 42%.

  • 2

    Study included 95,490 patients with depression/anxiety.

  • 3

    Follow-up period averaged 5.2 years.

  • 4

    Within-patient design used to mitigate confounding factors.

  • 5

    Liraglutide showed modest benefits; exenatide and dulaglutide showed no impact.

  • 6

    81.5% of participants had anxiety disorders.

  • 7

    Study author: Heidi Taipale, PhD, University of Eastern Finland.

Original Source(s)

GLP-1 Drugs Examined in Psychiatric Outcomes

  • by Kathryn Wighton

  • March 26, 2026

Related Content

Trial Tests Single-Day TRD Treatment 

Randomized trial found more than half of treated patients achieved remission within 8 days.

Medical Oddities: When Men Face Catcalling

Cooking, catcalling, and colon swaps—medicine keeps things interesting.

Moral Distress Associated With Physician Burnout

Researchers link distress to burnout, professional fulfillment, and intent to leave or reduce clinical hours.